In the months of April to June, the group turnover rose compared to the same quarter last year by 31 percent to 8.2 billion dollars, as Astrazeneca announced on Thursday. With the vaccination alone, the company made almost $ 900 million – more than three times as much as in the first quarter. Without the vaccine, the increase in sales was 17 percent.
However, increasing expenses and the Group’s voluntary commitment not to make a profit with the corona vaccine put pressure on profitability. The bottom line was that profits fell from $ 756 million in the same period last year to $ 550 million.